Clinical characteristics and treatment outcomes of kidney transplant recipients with de novo urothelial carcinoma: thirty years of experience from a single center

Table 3 The P value in different group

		Rapamycin			Bladder infusion Chemotherapy			GC/GCa chemotherapy			CNI drugs
		OS	RFS	PFS	OS	RFS	PFS	OS	RFS	PFS	OS	RFS	PFS
BC
	T1 and lower stage	-	-	-	-	0.071	0.4	-	-	-	0.281	0.755	0.937
UTUC
	T1 and lower stage	0.057	-	0.122	0.343	-	0.199	-	-	-	0.187	-	0.017
	T2 and higher stage	0.317	-	0.026	-	-	-	0.132	-	0.521	-	-	-
BC + UTUC
	T1 and lower stage	0.225	0.98	0.274	0.665	0.778	0.228	-	-	-	0.672	0.361	0.895
	T2 and higher stage	0.602	0.362	0.436	0.284	0.697	0.825	0.507	0.885	0.436	-	-	-

ISSN: 1471-2490